home / stock / blco / blco news


BLCO News and Press, Bausch + Lomb Corporation From 01/08/24

Stock Information

Company Name: Bausch + Lomb Corporation
Stock Symbol: BLCO
Market: NYSE
Website: bausch.com

Menu

BLCO BLCO Quote BLCO Short BLCO News BLCO Articles BLCO Message Board
Get BLCO Alerts

News, Short Squeeze, Breakout and More Instantly...

BLCO - Bausch + Lomb drops amid comments at JPMorgan Healthcare Conference

2024-01-08 16:17:29 ET More on Bausch + Lomb Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch + Lomb Corporation (BLCO) Q3 2023 Earnings Call Transcript Bausch + Lomb wins FDA nod for eye surgery product Bausch + Lomb Non-GAAP EPS of $0.22 beat...

BLCO - Bausch Health gains after an appeals hearing in Norwich case over generic Xifaxan

2024-01-08 13:53:28 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...

BLCO - Bausch + Lomb wins FDA nod for eye surgery product

2024-01-08 08:31:17 ET More on Bausch Health, Bausch + Lomb, etc. Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch re...

BLCO - Bausch + Lomb Receives FDA Approval for TENEO(TM) Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery

First Excimer Platform Approved in Nearly Two Decades Offers Accuracy, Efficiency and Usability Advantages Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. Food and Drug Admi...

BLCO - When (BLCO) Moves Investors should Listen

2024-01-06 13:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BLCO - Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat with investors at the 42 nd Annual J.P. Morgan Healthcare Conference ...

BLCO - FDA's new drug approvals for 2023 rise 51% from last year

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

BLCO - Tracking Carl Icahn's 13F Report - Q3 2023 Update

2023-12-10 22:56:31 ET Summary Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. The top five holdings in the filing are Icahn Enterprises, CVR Energy, Occidental Petroleum warrants, Southwest Gas Holdings, and FirstEnergy. Icahn disposed of his stake in X...

BLCO - National Vision: Eyes Set Toward The Future

2023-12-10 17:00:00 ET Summary National Vision Holdings has experienced a decline in stock price due to the termination of its partnership with Walmart. Despite mixed financial performance, the company has a plan to recoup losses and it offers investors upside potential. The s...

BLCO - Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

2023-11-30 05:33:24 ET Summary Bausch Health has a solid business model with steady revenue generation and strong operating income margins - but debt & litigation are crippling the business. The company's heavy debt of >$20bn, and pending litigation around lead product Xifa...

Previous 10 Next 10